Vir Biotechnology, Inc. Insider Trading for April 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vir Biotechnology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vir Biotechnology, Inc. for April 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 28 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 7,900 | 12,087 | 304,255 | |
Apr 28 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 49.50 | 7,900 | 391,077 | 91,700 | 99.6 K to 91.7 K (-7.93 %) |
Apr 28 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 7,900 | 12,087 | 99,600 | 91.7 K to 99.6 K (+8.62 %) |
Apr 28 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 7,900 | 12,087 | 304,255 | |
Apr 28 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 49.50 | 7,900 | 391,077 | 91,700 | 99.6 K to 91.7 K (-7.93 %) |
Apr 28 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 7,900 | 12,087 | 99,600 | 91.7 K to 99.6 K (+8.62 %) |
Apr 20 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 2,340 | 3,580 | 312,155 | |
Apr 20 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 48.00 | 2,340 | 112,320 | 91,700 | 94 K to 91.7 K (-2.49 %) |
Apr 20 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 2,340 | 3,580 | 94,040 | 91.7 K to 94 K (+2.55 %) |
Apr 19 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 3,500 | 5,355 | 314,495 | |
Apr 19 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 3,500 | 5,355 | 91,700 | 88.2 K to 91.7 K (+3.97 %) |
Apr 15 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 5,560 | 8,507 | 317,995 | |
Apr 15 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 43.57 | 5,560 | 242,244 | 88,200 | 93.8 K to 88.2 K (-5.93 %) |
Apr 15 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 5,560 | 8,507 | 93,760 | 88.2 K to 93.8 K (+6.30 %) |
Apr 12 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 14,000 | 21,420 | 323,555 | |
Apr 12 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 14,000 | 21,420 | 88,200 | 74.2 K to 88.2 K (+18.87 %) |
Apr 12 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 14,000 | 21,420 | 323,555 | |
Apr 12 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 14,000 | 21,420 | 88,200 | 74.2 K to 88.2 K (+18.87 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,989 | 0 | 23,954 | 18 K to 24 K (+33.34 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,051,678 | 15.3 M to 15.1 M (-1.84 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 11,614,985 | 11.8 M to 11.6 M (-1.84 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,989 | 0 | 17,965 | 12 K to 18 K (+50.01 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,333,897 | 15.6 M to 15.3 M (-1.81 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 11,832,766 | 12.1 M to 11.8 M (-1.81 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 1,019 | 0 | 4,068 | 3 K to 4.1 K (+33.42 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 3,161 | 0 | 12,642 | 9.5 K to 12.6 K (+33.34 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 282,219 | 0 | 15,051,678 | 15.3 M to 15.1 M (-1.84 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 217,781 | 0 | 11,614,985 | 11.8 M to 11.6 M (-1.84 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 1,019 | 0 | 3,049 | 2 K to 3 K (+50.20 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 3,161 | 0 | 9,481 | 6.3 K to 9.5 K (+50.02 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 282,219 | 0 | 15,333,897 | 15.6 M to 15.3 M (-1.81 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 217,781 | 0 | 11,832,766 | 12.1 M to 11.8 M (-1.81 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,987 | 0 | 11,976 | 6 K to 12 K (+99.97 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,616,116 | 15.9 M to 15.6 M (-1.78 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 12,050,547 | 12.3 M to 12.1 M (-1.78 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,989 | 0 | 5,989 | 0 to 6 K |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,898,335 | 16.2 M to 15.9 M (-1.74 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 12,268,328 | 12.5 M to 12.3 M (-1.74 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 1,016 | 0 | 2,030 | 1 K to 2 K (+100.20 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 3,160 | 0 | 6,320 | 3.2 K to 6.3 K (+100.00 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 282,219 | 0 | 15,616,116 | 15.9 M to 15.6 M (-1.78 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 217,781 | 0 | 12,050,547 | 12.3 M to 12.1 M (-1.78 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 1,014 | 0 | 1,014 | 0 to 1 K |
Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 3,160 | 0 | 3,160 | 0 to 3.2 K |
Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 282,219 | 0 | 15,898,335 | 16.2 M to 15.9 M (-1.74 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 217,781 | 0 | 12,268,328 | 12.5 M to 12.3 M (-1.74 %) |